Theralink Technologies Inc (THER)

Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
3
11441 INDUSTRIPLEX BLVD, SUITE 190, BATON ROUGE, LA 70809
225-227-2384

N/A

Data derived from most recent annual or quarterly report
Market Cap 416.66 Million Shares Outstanding5.555 Billion Avg 30-day Volume 11.729 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price to Revenue985.87 Debt to Equity-0.5244 EBITDA-5.016 Million
Price to Book Value0.0 Operating Margin-1183.6482999999998 Enterprise Value464.389 Million
Current Ratio0.4 EPS Growth0 Quick Ratio0.285
1 Yr BETA -3.3624 52-week High/Low 0.0 / Profit Margin-1290.4585
Operating Cash Flow Growth-5.8043 Altman Z-Score40.8367 Free Cash Flow to Firm -4.413 Million
View SEC Filings from THER instead.

View recent insider trading info

Funds Holding THER (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding THER BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-04-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-29:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-08:
    Item 9.01: Financial Statements and Exhibits
    Item 4.01: Changes in Registrant's Certifying Accountant
  • 8-K: filed on 2021-05-19:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2021-04-20:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-04-20:
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
  • 8-K: filed on 2021-04-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HOLLEY DANICA

    • Director
    2,150,840 2022-06-15 2

    SCHWARTZ MATTHEW WILSON

    • Director
    61,380,192 2022-04-01 1

    CHILCOTT, III THOMAS E. CHIEF FINANCIAL OFFICER

    • Officer
    0 2020-09-24 0

    BUSCH JEFFREY

    • Director
    0 2020-06-18 0

    FORS YVONNE

    • Director
    0 2020-06-18 0

    RUXIN MICHAEL I CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2020-06-05 0

    AVANT DIAGNOSTICS, INC

    • 10% Owner
    0 2020-06-05 0

    KUCHARCHUK ANDREW ALBERT

    • Director
    0 2020-06-05 0

    HEAD JONATHAN FREDERICK

    • Director
    189,236 2020-05-07 0

    RICE CHARLES L JR

    • Director
    0 2019-04-24 0

    HOLCOMB ROBERT NEAL

    • Director
    0 2019-04-24 0

    HOVERMAN DANIEL S.

    • Director
    0 2019-04-24 0

    BARNETT BRIAN GILL

    • Director
    0 2019-04-24 0

    ODABACHIAN MANUEL COSME GLOBAL OPERATIONS GM-VITEL

    • Officer
    • Director
    • 10% Owner
    33,079,007 2017-03-10 0

    VOLNIE CARLOS FERNANDO ALAMAN CHIEF OPERATING OFFICER-VITEL

    • Officer
    • 10% Owner
    33,079,006 2017-03-10 0

    ELLIOT ROBERT LANGE JR

    • Director
    0 2015-09-02 0

    LEONE GROUP, LLC

    • 10% Owner
    No longer subject to file 2015-08-27 0

    AMERICAN CAPITAL VENTURES, INC.

    • 10% Owner
    No longer subject to file 2015-08-27 0

    DIETRICH CONSTANTIN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    35,848,272 2015-05-18 0

    CARUSONE JOSEPH VP, INVESTOR RELATIONS#

    • Officer
    • Director
    No longer subject to file 2015-03-10 0

    RICHARDSON PAUL JOHN

    • Director
    0 2011-09-15 0

    TOUSLEY DAVID L. TREASURER SECRETARY CFO

    • Officer
    • Director
    400,000 2011-03-04 0

    RODRIGUEZ JORGE ENRIQUE VP & CHIEF COMMERCIAL OFFICER

    • Officer
    0 2011-03-04 0

    DURRANT CAMERON PRESIDENT, CEO

    • Officer
    • Director
    • 10% Owner
    4,250,000 2011-02-09 0

    CARUSONE JOSEPH PRESIDENT SECRETARY TREASURER

    OPEX ENERGY CORP.

    • Officer
    • Director
    • 10% Owner
    5,300,000 2010-11-03 0

    OPEX ENERGY CORP.

    • 10% Owner
    5,000,000 2008-08-18 0

    COLE BRIAN DIRECTOR AND CORP. SECRETARY

    • Officer
    • Director
    200,000 2007-06-21 0

    GREGOVIC KONSTANTIN

    • Director
    • CHAIRMAN OF AUDIT COMMITTEE
    1,000 2007-02-07 0

    PERGER SHAWN PRESIDENT, SECRETARY/TREASURER

    • Officer
    • Director
    • 10% Owner
    5,000,000 2006-11-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HOLLEY DANICA - Director

    2022-06-22 17:16:24 -0400 2022-06-15 J 2,100,840 a 2,100,840 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    THERALINK TECHNOLOGIES INC THER 2022-06-20 22:15:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 21:45:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 21:15:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 20:45:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 20:15:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 19:45:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 19:15:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 18:45:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 18:15:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 17:45:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 17:15:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 16:45:02 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 16:15:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 15:45:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 15:15:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 14:45:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 14:15:04 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 13:45:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 13:15:03 UTC 1.32 0.25 100
    THERALINK TECHNOLOGIES INC THER 2022-06-20 12:45:03 UTC 1.32 0.25 100

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments